Reliable one-step assessment of IGHV mutational status and gene mutations in Chronic Lymphocytic Leukemia by capture-based high throughput sequencing.
Le Bris, Y.; Thonier, F.; Menard, A.; Theisen, O.; Mahe, B.; Lok, A.; Bouzy, S.; Bene, M. C.
Show abstract
Proper management of chronic lymphocytic leukemia (CLL) patients requiring therapy relies on two important prognostic and theranostic molecular features: respectively, the mutational status of tumoral cells immunoglobulin heavy chain variable domain (IGHV) and the characteristics of TP53. Both these (immuno)genetic analyses require multiple time-consuming amplification and sequencing techniques by Sanger or HTS. The capture-HTS technology, allowing to select regions of interest, represents an attractive alternative and has already been applied for the detection of clonality in lymphoproliferative disorders. Here, a single-step capture design was developed to concomitantly investigate for IGHV and TP53. This was applied to a training retrospective (n=14) and a validation prospective (n=91) cohorts of CLL patients. The training cohort demonstrated the robustness of the method by comparison with the classical Sanger sequencing technology (100% identical results) for the IGHV mutational status. This consistency was confirmed for the first 59 patients of the validation cohort. Overall, the IGHV status of whole population (n=103) was accurately identified. Simultaneously, deletion or mutations of TP53 were identified from the same capture-library and HTS-sequencing run for each patient. This novel approach provides, in a single assay, useful answers about the molecular landscape of CLL patients, allowing for a documented choice of therapy. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=115 SRC="FIGDIR/small/483581v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@91685forg.highwire.dtl.DTLVardef@5b47baorg.highwire.dtl.DTLVardef@c2286corg.highwire.dtl.DTLVardef@ebd413_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Poorly expressed alleles of several human immunoglobulin heavy chain variable (IGHV) genes are common in the human population 93%
- AIRR-C Human IG Reference Sets: curated sets of immunoglobulin heavy and light chain germline genes 92%
- Specific induction of double negative B cells during protective and pathogenic immune responses 92%
Similar papers in this journal
- Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms 93%
- Inhibition of Casein Kinase 2 induces cell death in chronic myelogenous leukemia cells resistant to tyrosine kinase inhibitors 91%
- Utilisation of semiconductor sequencing for the detection of predictive biomarkers in glioblastoma 91%
Similar papers in this journal
- A novel triple-action inhibitor targeting B-cell receptor signaling and BRD4 demonstrates preclinical activity in chronic lymphocytic leukemia 92%
- Excess BAFF Alters NR4As Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-cells in the Context of HIV-1 infection 90%
- Identification of ATP2B4 regulatory element containing functional genetic variants associated with severe malaria 89%
Similar papers in this journal
- Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay 90%
- Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers 90%
- Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests 89%
Similar papers in this journal
- Cas9-directed long-read sequencing to resolve optical genome mapping findings in leukemia diagnostics. 93%
- Tissue and Peripheral T-cell Repertoire Predicts Immunotherapy Response and Progression-Free Survival in NSCLC Patients 91%
- Performance Comparison of a Flow Cytometry-based and Two Commercial Chemiluminescent Immunoassays for Detection and Quantification of Antibodies Binding to SARS-CoV-2 Spike Protein 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.